New insight into clinical risk scores for patients with acute coronary syndromes

American Heart Journal

Volumn 146, Issue 5, 2003, Pages 754-756

  Morrow, David A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; EDITORIAL; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; MORTALITY; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; ST SEGMENT ELEVATION;

EID: 0242551637     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00460-5     Document Type: Editorial

References (21)

1. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article: a report of the ACC/AHA task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2002;40:1366-74.
2. Braunwald E, Mark D, Jones R, et al. Unstable angina: diagnosis and management. Clinical practice guideline number 10. AHCPR publication no. 94-0602. Rockville (Md): Agency for Health Care Policy and Research and the NHLBI, Public Health Service, US Department of Health and Human Services; 1994:154.
3. Scirica BM, Cannon CP, McCabe CH, et al. Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classification. Am J Cardiol 2002;90:821-6.
4. Jacobs DR Jr, Kroenke C, Crow R, et al. PREDICT: A simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota heart survey. Circulation 1999;100:599-607.
5. Boersma E, Pieper KS, Steyerberg EW, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation 2000;101:2557-67.
6. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000;284:835-42.
7. Brilakis ES, Wright RS, Kopecky SL, et al. Association of the PURSUIT risk score with predischarge ejection fraction, angiographic severity of coronary artery disease, and mortality in a nonselected, community-based population with non-ST-elevation acute myocardial infarction. Am Heart J 2003;146:811-8.
8. Weintraub WS. Prediction scores after myocardial infarction: value, limitations, and future directions. Circulation 2002;106: 2292-3.
9. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36.
10. Mathew V, Farkouh M, Grill DE, et al. Clinical risk stratification correlates with the angiographic extent of coronary artery disease in unstable angina. J Am Coll Cardiol 2001;37:2053-8.
11. Morrow DA, Sabatine MS, Cannon CP, et al. Higher TIMI Risk Score is associated with coronary thrombus and abnormal flow in non-ST elevation acute coronary syndromes: observations from PRISM-PLUS [abstract]. Circulation 2001;104:II-648.
12. Morrow DA, Antman EM, Snapinn SM, et al. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J 2002;23:223-9.
13. Singh M, Reeder GS, Jacobsen SJ, et al. Scores for post-myocardial infarction risk stratification in the community. Circulation 2002;106:2309-14.
14. Cannon CP. Evidence-based risk stratification to target therapies in acute coronary syndromes. Circulation 2002;106:1588-91.
15. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-87.
16. Cannon CP, O'Gara PT. Critical pathway for unstable angina. In: Cannon CP, O'Gara PT, editors. Critical pathways in cardiology. New York: Lippincott Williams & Wilkins; 2001:131-41.
17. Reilly BM, Evans AT, Schaider JJ, et al. Impact of a clinical decision rule on hospital triage of patients with suspected acute cardiac ischemia in the emergency department. JAMA 2002;288: 342-50.
18. Morrow DA, Antman EM, Charlesworth A, et al. TIMI Risk Score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. An InTIME II substudy. Circulation 2000;102:2031-7.
19. Giugliano RP, Llevadot J, Wilcox RG, et al. Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis: results from InTIME-II. Eur Heart J 2001;22:1702-15.
20. Sabatine MS, Morrow DA, Giugliano RP, et al. Implications of upstream GPIIB/IIIA inhibition and stenting in the invasive management of UA/NSTEMI: a comparison of TIMI IIIB and TACTICS-TIMI 18 [abstract]. Circulation 2001;104:II-549.
21. Krumholz HM, Chen J, Wang Y, et al. Comparing AMI mortality among hospitals in patients 65 years of age and older: evaluating methods of risk adjustment. Circulation 1999;99: 2986-92.